Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 2012

View Archived Issues

Researchers from Canada link CX3CR1 to neural degeneration in CSM

JNJ-41477670: a novel TRPA1 antagonist with a promising pharmacokinetic profile

Millennium presents first clinical results for two of its anticancer compounds

Genetic variations shared between obesity and ADHD identified

Durable immune responses seen in vivo with HSV-2 vaccine

Prosensa advances DMD candidates, obtains orphan drug designations

PTC Therapeutics receives NIH funding for dengue research

Biotica Technology discloses new cyclophilin A inhibitors

Amicus achieves target enrollment in phase III migalastat hydrochloride study

Interim 6-month results of 2-year extension STEPS2 trial presented

Novel antibacterial agents patented by Brown University

Lilly reports results from three phase III AWARD trials

Researchers at GE Healthcare divulge new PET imaging agents

AIM Therapeutics commences dosing in phase II AIM-102 trial

Novel TRPV3 channel inhibitors disclosed by Abbott Laboratories

Merck & Co. patents new compounds for cancer

Corcept Therapeutics presents new glucocorticoid receptor antagonists

FDA approves extended-release formulation of oxcarbazepine

Cel-Sci reports interim review results from phase III Multikine study

ISTO Technologies plans phase II NuQu study in discogenic back pain

LabCorp to develop tuberculosis antimicrobial susceptibility test using B-SMART

Minimally invasive non-small cell lung cancer model devised

AnGes and Mitsubishi Tanabe Pharma agree on Collategene U.S. rights

Avanir receives Michael J. Fox Foundation grant to study AVP-923

SARcode Bioscience discloses topline results from phase III lifitegrast study

Cosmo Pharmaceuticals reports data from phase II methylene blue MMX study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...